Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy
Status:
Completed
Trial end date:
2002-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to compare the effectiveness of epoetin alfa treatment on
hemoglobin (Hb) response, quality of life (QoL), health care resource utilization and patient
productivity when epoetin alfa was administered during chemotherapy to patients with mild
anemia or after waiting until patients became moderately anemic. Patients with lymphoma,
chronic lymphocytic leukemia (CLL) or Multiple Myeloma (MM) were studied.